UNSPSC 41181532: Beta-2-glycoprotein i immunological test system

In this classification, a Beta-2-glycoprotein i immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Beta-2-glycoprotein i. US FDA regulates Beta-2-glycoprotein i immunological test system under 21 CFR 866.5430 and under FDA product code DDN.

UNSPSC 41181532 Beta-2-glycoprotein I immunological test system is a Commodity code that shows no recent state and local procurement activity aligned with its nominal scope. The recent opportunities posted under this code span optical surface profilometers, airfield photometric testing, drug discovery software, meter test boards, high-voltage capacitance modules, sterilization equipment maintenance, atmospheric monitoring instruments, nanoindentation systems, laboratory testing services, spectrophotometers, transformer oil analysis, and landscape engineering services—none of which relate to immunological testing for beta-2-glycoprotein I or to immunological testing systems generally. The code appears to be misapplied across heterogeneous laboratory and engineering equipment procurements, suggesting either systematic tagging errors in the underlying procurement databases or a code that lacks current relevant activity.

State and local issuing bodies posting opportunities tagged to this code include higher education institutions (Valencia College, Jackson State University, Texas State University, Texas A&M University System), municipal utilities (City of Ocala Electric Utility, Kissimmee Utility Authority, City of Phoenix Water Services, Lubbock Power & Light, City of Tampa), county and regional authorities (Lee County Port Authority, Collier County, Marion County Oregon), state health agencies (Texas Department of State Health Services), and a state patrol division (Colorado State Patrol). Most recent activity clusters in Florida and Texas, with secondary postings from Arizona, Colorado, Oregon, and North Carolina. Without meaningful alignment between the code's stated purpose and the work actually being solicited, this code presents minimal pursuit opportunity for firms focused on immunological test systems or diagnostics.